These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3897395)

  • 1. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berg JC; Michel MF
    J Infect Dis; 1985 Aug; 152(2):373-8. PubMed ID: 3897395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Michel MF
    Antimicrob Agents Chemother; 1986 Sep; 30(3):403-8. PubMed ID: 3535664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S33-40. PubMed ID: 3325928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel BM
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):878-87. PubMed ID: 2512132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1019-25. PubMed ID: 1839380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1809-15. PubMed ID: 3324962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.
    Bakker-Woudenberg IA; ten Kate MT; Goessens WH; Mouton JW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2919-25. PubMed ID: 16940082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
    Bakker-Woudenberg IA; ten Kate MT; Stearne-Cullen LE; Woodle MC
    J Infect Dis; 1995 Apr; 171(4):938-47. PubMed ID: 7706822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
    McColm AA; Shelley E; Ryan DM; Acred P
    J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
    Cousson J; Floch T; Vernet-Garnier V; Appriou M; Petit JS; Jovenin N; Lamiable D; Hoizey G
    Pathol Biol (Paris); 2005; 53(8-9):546-50. PubMed ID: 16023303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
    Wang WF; Liu YN; She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):390-4. PubMed ID: 17045021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia.
    McNabb JJ; Nightingale CH; Quintiliani R; Nicolau DP
    Pharmacotherapy; 2001 May; 21(5):549-55. PubMed ID: 11349744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.
    Schiffelers RM; Storm G; ten Kate MT; Stearne-Cullen LE; den Hollander JG; Verbrugh HA; Bakker-Woudenberg IA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):369-75. PubMed ID: 11408564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment.
    Veillette JJ; Truong J; Forland SC
    Pharmacotherapy; 2016 Nov; 36(11):e172-e177. PubMed ID: 27716983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Echeverría O; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 2005 Feb; 55(2):209-13. PubMed ID: 15650000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.